SPL 2.20% 8.9¢ starpharma holdings limited

Ann: SPL7013 shows potent antiviral activity in RSV, page-3

  1. 90 Posts.
    lightbulb Created with Sketch. 67
    Progress!
    ”SPL7013 has been formulated into a preventative antiviral nasal spray, VIRALEZE, which is now in the late stages of development and on track to be commercially available in H1 2021, with first launches expected to occur in Europe and other regions to follow”
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
-0.002(2.20%)
Mkt cap ! $36.67M
Open High Low Value Volume
9.3¢ 9.3¢ 8.9¢ $29.39K 323.4K

Buyers (Bids)

No. Vol. Price($)
2 242435 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 20000 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.